For instance, the development and progression of various disorders comprising OA, rheumatoid arthritis (RA), fibrotic conditions, and cancer are associated with abnormal ECM remodeling, which drives disease progression by activating specific cell surface receptors and downstream signaling cascades that regulate cell-matrix-interactions [22,27]. This evidence concerns the gene CD177 and cancer.